PRMT7 and breast carcinoma: Furthermore, an assessment of PRMT7 expression using the unbiased genome-wide databases, ‘The Cancer Genome Atlas’, ‘Oncomine’ and the ‘ABREN’ revealed that it is dysregulated in breast cancer.